中西医诊治重症肺炎的研究进展
Progress in Diagnosis and Treatment of Severe Pneumonia with Chinese and Western Medicine
DOI: 10.12677/tcm.2024.138259, PDF,   
作者: 唐歆靖:广西中医药大学研究生院,广西 南宁
关键词: 重症肺炎中西医研究进展Severe Pneumonia Research Progress of Chinese and Western Medicine
摘要: 重症肺炎(Severe pneumonia, SP)是近年来全球范围内出现的一种严重的呼吸系统疾病,其发病机制复杂,治疗难度大。SP的发病机制主要涉及氧化应激反应、宿主免疫反应和病原体侵入等方面。目前,治疗SP的方法主要包括抗感染、机械通气、抗休克、循环支持等药物治疗,中医药作为中医药文化的重要组成部分,在SP的防治上也有着不俗的成效。本文基于相关文献研究,将对SP的中西医研究进展做一综述,为SP的治疗及中医药防治SP研究提供参考,同时也对中医药的发展与推广起到积极的推动作用。
Abstract: Severe pneumonia is a serious respiratory disease that has emerged worldwide in recent years, and its pathogenesis is complex and difficult to treat. The pathogenesis of SP mainly involves oxidative stress response, host immune response and pathogen invasion and so on. At present, the treatment of SP mainly includes anti-infection, mechanical ventilation, anti-shock, circulatory support and other drug treatment, traditional Chinese medicine as an important part of the culture of traditional Chinese medicine, in the prevention and treatment of SP has also had remarkable results. Based on the relevant literature research, this article will review the research progress of SP in Chinese and Western medicine, provide a reference for the treatment of SP and the prevention and treatment of SP by Chinese medicine, and also play a positive role in promoting the development and promotion of Chinese medicine.
文章引用:唐歆靖. 中西医诊治重症肺炎的研究进展[J]. 中医学, 2024, 13(8): 1715-1722. https://doi.org/10.12677/tcm.2024.138259

参考文献

[1] 丁存香. 重症肺炎免疫失衡机制及中医药治疗进展分析[J]. 内蒙古中医药, 2024, 43(2): 162-164.
[2] Li, Z.J., Zhang, H.Y., Ren, L.L., et al. (2021) Etiological and Epidemiological Features of Acute Respiratory Infections in China. Nature Communications, 12, Article No. 5026. [Google Scholar] [CrossRef] [PubMed]
[3] Cilloniz, C., Torres, A. and Niederman, M.S. (2021) Management of Pneumonia in Critically Ill Patients. BMJ, 375, e65871. [Google Scholar] [CrossRef] [PubMed]
[4] Goel, N.N., Chen, J.T., Roberts, R., et al. (2022) Effects of Timing of Invasive Mechanical Ventilation in Patients with Shock. An Analysis of the Multicenter Prospective Observational VOLUME-CHASERS Cohort. Journal of Intensive Care Medicine, 37, 1435-1441. [Google Scholar] [CrossRef] [PubMed]
[5] Sarda, C., Fazal, F. and Rello, J. (2019) Management of Ventilator-Associated Pneumonia (VAP) Caused by Resistant Gram-Negative Bacteria: Which Is the Best Strategy to Treat? Expert Review of Respiratory Medicine, 13, 787-798. [Google Scholar] [CrossRef] [PubMed]
[6] 达明冬, 杨海明, 司立宁, 等. 重症肺炎革兰阴性菌分离株耐药性及其碳青霉烯酶基因检测[J]. 中华医院感染学杂志, 2023, 33(18): 2733-2736.
[7] 张静, 李雨珂, 王臻, 等. 重症肺炎患者多药耐药菌感染的病原学及影响因素模型构建[J]. 中华医院感染学杂志, 2023, 33(23): 3552-3556.
[8] Su, D.-Q., Huang, H.-L. and Zhuo, Z.-Q. (2021) Pathogen Distribution and Bacterial Resistance in Children with Severe Pneumonia: A Single-Center Retrospective Study. Medicine (Baltimore), 100, e27128. [Google Scholar] [CrossRef
[9] 谢小馨, 彭银霜, 何金洪, 等. 重症肺炎患者肺部感染的病原学特征及耐药性分析[J]. 中国病原生物学杂志, 2024, 19(2): 217-220.
[10] Guo, L.N., Xiao, M., Cao, B., et al. (2017) Epidemiology and Antifungal Susceptibilities of Yeast Isolates Causing Invasive Infections across Urban Beijing, China. Future Microbiology, 12, 1075-1086. [Google Scholar] [CrossRef] [PubMed]
[11] 张立平, 丁风琴, 邓丽, 等. 2012-2021年临床侵袭性真菌感染分布及耐药性分析[J]. 宁夏医学杂志, 2023, 45(11): 1034-1037.
[12] Jiang, L.X., Ren, H.Y., Zhou, H.J., et al. (2017) Simultaneous Detection of Nine Key Bacterial Respiratory Pathogens Using Luminex xTAG Technology. International Journal of Environmental Research and Public Health, 14, Article No. 223. [Google Scholar] [CrossRef] [PubMed]
[13] 吴娜, 李永霞. mNGS在肺部感染中的诊断标准及标本选择研究进展[J]. 中国老年保健医学, 2021, 19(5): 122-124.
[14] Stearns-Kurosawa, D.J., Osuchowski, M.F., Valentine, C., et al. (2011) The Pathogenesis of Sepsis. Annual Review of Pathology: Mechanisms of Disease, 6, 19-48. [Google Scholar] [CrossRef] [PubMed]
[15] Quinton, L.J., Walkey, A.J. and Mizgerd, J.P. (2018) Integrative Physiology of Pneumonia. Physiological Reviews, 98, 1417-1464. [Google Scholar] [CrossRef] [PubMed]
[16] Tavares, L.P., Teixeira, M.M. and Garcia, C.C. (2017) The Inflammatory Response Triggered by Influenza Virus: A Two Edged Sword. Inflammation Research, 66, 283-302. [Google Scholar] [CrossRef] [PubMed]
[17] Hotchkiss, R.S., Swanson, P.E., Freeman, B.D., et al. (1999) Apoptotic Cell Death in Patients with Sepsis, Shock, and Multiple Organ Dysfunction. Critical Care Medicine, 27, 1230-1251. [Google Scholar] [CrossRef] [PubMed]
[18] Hotchkiss, R.S., Tinsley, K.W., Swanson, P.E., et al. (2001) Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans. The Journal of Immunology, 166, 6952-6963. [Google Scholar] [CrossRef] [PubMed]
[19] Venet, F., Chung, C.S., Monneret, G., et al. (2008) Regulatory T Cell Populations in Sepsis and Trauma. Journal of Leukocyte Biology, 83, 523-535. [Google Scholar] [CrossRef] [PubMed]
[20] Hotchkiss, R.S., Tinsley, K.W., Swanson, P.E., et al. (2002) Depletion of Dendritic Cells, but Not Macrophages, in Patients with Sepsis. The Journal of Immunology, 168, 2493-2500. [Google Scholar] [CrossRef] [PubMed]
[21] Felmet, K.A., Hall, M.W., Clark, R.S., et al. (2005) Prolonged Lymphopenia, Lymphoid Depletion, and Hypoprolactinemia in Children with Nosocomial Sepsis and Multiple Organ Failure. The Journal of Immunology, 174, 3765-3772. [Google Scholar] [CrossRef] [PubMed]
[22] Hotchkiss, R.S., Monneret, G. and Payen, D. (2013) Sepsis-Induced Immunosuppression: From Cellular Dysfunctions to Immunotherapy. Nature Reviews Immunology, 13, 862-874. [Google Scholar] [CrossRef] [PubMed]
[23] Hotchkiss, R.S., Monneret, G. and Payen, D. (2013) Immunosuppression in Sepsis: A Novel Understanding of the Disorder and a New Therapeutic Approach. The Lancet Infectious Diseases, 13, 260-268. [Google Scholar] [CrossRef
[24] Leli, C., Ferranti, M., Moretti, A., et al. (2015) Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections. Disease Markers, 2015, Article ID: 701480. [Google Scholar] [CrossRef] [PubMed]
[25] Wang, D., Tao, X., Guo, W., Liu, H., Cheng, S. and Wang, J. (2019) The Diagnostic Ability of Procalcitonin to Differentiate Gram-Negative Bacteria from Gram-Positive Bacteria and Fungal Bloodstream Infections in Critically Ill Patients. European Journal of Inflammation, 17, 1930-1945. [Google Scholar] [CrossRef
[26] Becker, K.L., Nylén, E.S., White, J.C., Müller, B. and Snider, R.H. (2004) Clinical Review 167: Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its Precursors. The Journal of Clinical Endocrinology & Metabolism, 89, 1512‐1525. [Google Scholar] [CrossRef] [PubMed]
[27] Matsumoto, H., Kasai, T., Sato, A., et al. (2019) Association between C-Reactive Protein Levels at Hospital Admission and Long-Term Mortality in Patients with Acute Decompensated Heart Failure. Heart Vessels, 34, 1961-1968. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, L. (2020) C-reactive Protein Levels in the Early Stage of COVID-19. Médecine et Maladies Infectieuses, 50, 332-334. [Google Scholar] [CrossRef] [PubMed]
[29] Sharifpour, M., Rangaraju, S., Liu, M., et al. (2020) C-Reactive Protein as a Prognostic Indicator in Hospitalized Patients with COVID-19. PLOS ONE, 15, e0242400. [Google Scholar] [CrossRef] [PubMed]
[30] Ferrer, M., Travierso, C., Cilloniz, C., et al. (2018) Severe Community-Acquired Pneumonia: Characteristics and Prognostic Factors in Ventilated and Non-Ventilated Patients. PLOS ONE, 13, e0191721. [Google Scholar] [CrossRef] [PubMed]
[31] Bouch, C. and Thompson, J.P. (2008) Severity Scoring Systems in the Critically Ill. Continuing Education in Anaesthesia, Critical Care & Pain, 8, 181-185. [Google Scholar] [CrossRef
[32] Mandell, L.A., Wunderink, R.G., Anzueto, A., et al. (2007) Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases, 44, S27-S72. [Google Scholar] [CrossRef] [PubMed]
[33] Jafrin, S., Aziz, M.A. and Islam, M.S. (2022) Elevated Levels of Pleiotropic Interleukin-6 (IL-6) and Interleukin-10 (IL-10) Are Critically Involved with the Severity and Mortality of COVID-19: An Updated Longitudinal Meta-Analysis and Systematic Review on 147 Studies. Biomark Insights, 17. [Google Scholar] [CrossRef
[34] Halim, C., Mirza, A.F. and Sari, M.I. (2022) The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis. Pathogens, 11, Article No. 195. [Google Scholar] [CrossRef] [PubMed]
[35] Li, H., Xiang, X., Ren, H., et al. (2020) Serum Amyloid A Is a Biomarker of Severe Coronavirus Disease and Poor Prognosis. Journal of Infection, 80, 646-655. [Google Scholar] [CrossRef] [PubMed]
[36] 尹元刚. 抗生素降阶梯治疗重症肺炎的临床效果及安全性分析[J]. 大医生, 2023, 8(2): 1-4.
[37] 邹林, 高翔, 张冲, 等. 2020-2022年北京市通州区呼吸道病原体流行特征分析[J]. 疾病监测, 2024: 1-11.
[38] 黎海燕, 扶红根, 丁国标, 等. 山莨菪碱联合布地奈德对肺炎感染患儿肺功能和免疫功能及细胞因子的影响[J]. 中华医院感染学杂志, 2020, 30(20): 3174-3179.
[39] 高华. 乙酰半胱氨酸溶液联合纤维支气管镜肺泡灌洗方案治疗重症肺炎患者的临床效果[J]. 国际感染病学(电子版), 2020, 9(1): 65.
[40] 王吉胜, 吴立存, 吴慧, 等. 雾化吸入乙酰半胱氨酸联合布地奈德治疗婴幼儿肺炎临床疗效观察[J]. 中华全科医学, 2021, 19(9): 1518-1521.
[41] 徐婷, 周潇. 机械振动排痰配合纤维支气管镜吸痰灌洗对重症肺炎并发呼吸衰竭患者肺功能及炎症状态的影响[J]. 医药高职教育与现代护理, 2021, 4(4): 319-322.
[42] 张海霞, 贾莉, 董燕, 等. 纤维支气管镜肺泡灌洗对肺癌合并呼吸机相关性肺炎患者肺功能及炎症因子的影响[J]. 中华医院感染学杂志, 2019, 29(17): 2611-2614.
[43] 张宇. 无创呼吸机在儿科呼吸系统疾病的研究进展分析[J]. 中国医疗器械信息, 2021, 27(24): 25-27.
[44] 刘超, 陈鹏. 老年重症肺炎治疗中无创呼吸机的应用效果评价[J]. 中华养生保健, 2023, 41(17): 166-168.
[45] 聂森. 无创呼吸机在老年重症肺炎所致呼吸衰竭治疗中的应用效果研究[J]. 中国现代药物应用, 2021, 15(3): 38-40.
[46] 邢晓莉. 无创呼吸机治疗高龄重症肺炎患者的临床研究进展[J]. 中国医疗器械信息, 2021, 27(14): 29-30+187.
[47] 田静静, 穆燕. 急诊重症肺炎并发感染性休克治疗的影响因素[J]. 中国城乡企业卫生, 2023, 38(11): 19-21.
[48] 闫红霞, 马磊, 颜彦, 等. 重症肺炎多重耐药菌感染危险因素及NLRP3/IL-1β的预测价值[J]. 中华医院感染学杂志, 2024(6): 812-815.
[49] 范铁兵, 杨志旭. 杨志旭治疗新型冠状病毒肺炎用药规律[J]. 山东中医杂志, 2022, 41(3): 321-325.
[50] 吕洪波, 吕顺武, 薛军堂. 麻杏石甘汤加减治疗风温肺热病痰热壅肺证临床研究[J]. 新中医, 2021, 53(8): 19-21.
[51] 罗朝湖. 痰热清注射液联合穴位贴敷对老年重症肺炎患者炎症因子的影响[J]. 中国当代医药, 2023, 30(5): 53-56.
[52] 董晶晶, 屈乐言. 俯卧位通气联合针刺治疗重症肺炎30例[J]. 光明中医, 2023, 38(1): 109-112.
[53] 蒋争艳, 蒋菲菲, 杨小凤, 等. 震动排痰仪联合穴位按摩对重症肺炎患者排痰效果的影响研究[J]. 当代护士(上旬刊), 2021, 28(8): 1-3.